Accelerated oxytocin titration protocol for labour dystocia demonstrates feasibility for large RCT.

Labour dystocia, or slow labour progress, is a common complication, particularly in nulliparous women, significantly increasing the risk of caesarean births. Current standard-of-care often involves labour augmentation with oxytocin, a synthetic form of the naturally occurring hormone, to stimulate uterine contractions. However, existing oxytocin titration protocols vary, and there's a clinical need to optimize administration strategies to improve labour outcomes and reduce surgical interventions without compromising maternal or neonatal safety. This pilot study investigates the feasibility of a novel accelerated oxytocin titration protocol.

The ACTION pilot study was designed as a feasibility assessment for a future large, multi-centre randomized controlled trial. It aimed to compare an accelerated titration protocol of oxytocin against a gradual titration protocol for labour augmentation in nulliparous patients experiencing labour dystocia. Key objectives included evaluating the feasibility of patient recruitment, randomization, and blinding, as well as assessing adherence to study protocols and labour management guidelines. The study also sought preliminary data on the acceptability of the accelerated protocol among obstetrical providers and participants, laying the groundwork for a definitive clinical trial.